Tigan Injection
Product Images NDC 0404-9964

2 FDA label images from Henry Schein, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tigan (NDC 0404-9964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure of Trimethobenzamide Hydrochloride, the active ingredient in Tigan injection. The diagram shows the molecular components and chemical bonds including aromatic rings, methoxy groups, and other functional groups characteristic of this compound.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Tigan (trimethobenzamide hydrochloride) injection label showing 200 mg/2 mL concentration, equivalent to 100 mg/mL. It is a single-dose vial for intramuscular use only, with warnings against pediatric use. The label includes storage instructions and manufacturer information for Henry Schein, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.